Breaking News Instant updates and real-time market news.

IQV

Iqvia

$118.37

7.005 (6.29%)

07:36
07/25/18
07/25
07:36
07/25/18
07:36

Iqvia price target raised to $135 from $120 at JPMorgan

JPMorgan analyst Tycho Peterson raised his price target for Iqvia to $135 citing the company's "strong" Q2 results. Broad-based momentum points to an attractive second half of the year setup for the shares, Peterson tells investors in a research note. He maintains an Overweight rating on Iqvia.

IQV Iqvia
$118.37

7.005 (6.29%)

06/18/18
BARD
06/18/18
UPGRADE
Target $127
BARD
Outperform
Iqvia upgraded to Outperform at Baird
As reported previously, Baird analyst Eric Coldwell upgraded Iqvia to Outperform from Neutral. The analyst cited its year-to-date underperformance versus peers and its relative and absolute valuation as "too disjointed to ignore." He expects strong one-year returns and views the shares as a long-term core holding. Coldwell raised his price target to $127 from $109 on Iqvia shares.
07/03/18
RAJA
07/03/18
UPGRADE
RAJA
Strong Buy
Iqvia upgraded to Strong Buy from Outperform at Raymond James
07/25/18
BOFA
07/25/18
UPGRADE
Target $135
BOFA
Buy
Iqvia upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Derik De Bruin upgraded Iqvia (IQV) to Buy from Neutral and raised its price target to $135 from $113 following recent Q2 results. De Bruin now expects growth to improve driven by higher win rates, solid CRO trends, and capital deployment via share buybacks and M&A.
07/25/18
LEHM
07/25/18
NO CHANGE
Target $130
LEHM
Overweight
Iqvia price target raised to $130 from $120 at Barclays
Barclays analyst Jack Meehan raised his price target for Iqvia to $130 saying the Q2 results "demonstrate many of the characteristics that the bulls have been waiting for on the thesis." Accelerating bookings momentum from the Next Generation platform and deployment of cash to drive earnings up 25% were highlights in the quarter, Meehan tells investors in a post-earnings research note. The analyst reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

ATHM

Autohome

$82.03

-0.91 (-1.10%)

07:12
07/19/19
07/19
07:12
07/19/19
07:12
Downgrade
Autohome rating change  »

Benchmark downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$10.88

-0.11 (-1.00%)

07:12
07/19/19
07/19
07:12
07/19/19
07:12
Hot Stocks
Cleveland-Cliffs expects to reach commercial production at Toledo HBI in 1H20 »

Cliffs now expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

ATRA

Atara Biotherapeutics

$15.27

0.25 (1.66%)

07:10
07/19/19
07/19
07:10
07/19/19
07:10
Syndicate
Atara Biotherapeutics 6.87M share Spot Secondary priced at $15.28 »

Citi, Goldman Sachs and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DFS

Discover

$81.65

1.62 (2.02%)

07:10
07/19/19
07/19
07:10
07/19/19
07:10
Hot Stocks
Discover names Jennifer Wong to board »

Discover announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 13

    Nov

CLF

Cleveland-Cliffs

$10.88

-0.11 (-1.00%)

07:10
07/19/19
07/19
07:10
07/19/19
07:10
Hot Stocks
Cleveland-Cliffs backs FY19 sales volume guidance of 20M long tons »

Backs FY19 production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

GRUB

GrubHub

$74.90

0.17 (0.23%)

07:09
07/19/19
07/19
07:09
07/19/19
07:09
Initiation
GrubHub initiated  »

GrubHub initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

07:05
07/19/19
07/19
07:05
07/19/19
07:05
General news
FX Update: The dollar settled at firmer levels »

FX Update: The dollar…

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

07:04
07/19/19
07/19
07:04
07/19/19
07:04
Recommendations
Intuitive Surgical analyst commentary  »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

IBKC

Iberiabank

$75.24

0.8 (1.07%)

07:04
07/19/19
07/19
07:04
07/19/19
07:04
Earnings
Iberiabank reports Q2 non-GAAP EPS $1.87, consensus $1.82 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 23

    Sep

CLF

Cleveland-Cliffs

$10.88

-0.11 (-1.00%)

07:04
07/19/19
07/19
07:04
07/19/19
07:04
Hot Stocks
Cleveland-Cliffs reports Q2 sales volume 6.2M long tons »

Reports Q2 production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

SLB

Schlumberger

$38.78

0.15 (0.39%)

07:04
07/19/19
07/19
07:04
07/19/19
07:04
Earnings
Schlumberger reports Q2 ex-items EPS 35c, consensus 35c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

HALO

Halozyme

$16.79

0.03 (0.18%)

, JNJ

Johnson & Johnson

$132.03

0.21 (0.16%)

07:02
07/19/19
07/19
07:02
07/19/19
07:02
Hot Stocks
Halozyme: Janssen submits extension application to EMA for DARZALEX »

Halozyme (HALO) announced…

HALO

Halozyme

$16.79

0.03 (0.18%)

JNJ

Johnson & Johnson

$132.03

0.21 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 15

    Oct

CLF

Cleveland-Cliffs

$10.88

-0.11 (-1.00%)

07:02
07/19/19
07/19
07:02
07/19/19
07:02
Earnings
Cleveland-Cliffs reports Q2 EPS 57c, consensus 52c »

Reports Q2 revenue $743M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

KBR

KBR

$25.28

0.36 (1.44%)

07:01
07/19/19
07/19
07:01
07/19/19
07:01
Upgrade
KBR rating change  »

KBR upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

ROK

Rockwell Automation

$159.17

-0.78 (-0.49%)

07:00
07/19/19
07/19
07:00
07/19/19
07:00
Recommendations
Rockwell Automation analyst commentary  »

JPMorgan's Tusa says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SXT

Sensient

$70.77

-0.48 (-0.67%)

07:00
07/19/19
07/19
07:00
07/19/19
07:00
Earnings
Sensient lowers 2019 adjusted EPS view to down 8%-9% from down 4%-7% »

Consensus for 2019 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:58
07/19/19
07/19
06:58
07/19/19
06:58
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

BLK

BlackRock

$474.98

4.06 (0.86%)

06:58
07/19/19
07/19
06:58
07/19/19
06:58
Hot Stocks
BlackRock CEO: Trend in China continues to be downward »

Says: Companies are not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:57
07/19/19
07/19
06:57
07/19/19
06:57
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CNK

Cinemark

$36.46

-1.31 (-3.47%)

06:57
07/19/19
07/19
06:57
07/19/19
06:57
Initiation
Cinemark initiated  »

Cinemark initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXT

Sensient

$70.77

-0.48 (-0.67%)

06:56
07/19/19
07/19
06:56
07/19/19
06:56
Earnings
Sensient reports Q2 EPS 81c, consensus 82c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

EYE

National Vision

$32.05

0.35 (1.10%)

06:56
07/19/19
07/19
06:56
07/19/19
06:56
Hot Stocks
National Vision names Melissa Rasmussen as Chief Accounting Officer »

National Vision announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

06:55
07/19/19
07/19
06:55
07/19/19
06:55
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDFN

Redfin

$16.84

-0.74 (-4.21%)

06:54
07/19/19
07/19
06:54
07/19/19
06:54
Initiation
Redfin initiated  »

Redfin initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

LYB

LyondellBasell

$85.70

-0.03 (-0.03%)

06:52
07/19/19
07/19
06:52
07/19/19
06:52
Initiation
LyondellBasell initiated  »

LyondellBasell reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.